The Ministry of Well being and Household Welfare (MoHFW) stated on Thursday that the federal government will compare the coronavirus vaccines – Covishield and Covaxin on different parameters for recordkeeping functions.
In accordance to the Union Well being Ministry, the comparability parameters will embrace vaccine platform, bodily specs, dosage, chilly chain storage necessities, and minor opposed occasions following the immunisation.
“Comparative factsheet for Covid-19 vaccines (Covishield and Covaxin) has been ready for recordkeeping functions. Comparability parameters will embrace vaccine platform, bodily specs, dosage, chilly chain storage necessities, and minor opposed occasions following immunisation,” stated the MoHFW.
India has given emergency use authorisation to two COVID-19 vaccines Covishield and Covaxin, each being manufactured within the nation.
Whereas Covishield has been developed by AstraZeneca and Oxford College, Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with ICMR.
Round three lakh healthcare employees might be inoculated at 2,934 websites throughout the nation on the primary day of the huge nationwide Covid-19 vaccination drive which is ready to start from January 16, the well being ministry stated.
(With ANI Inputs)
Newest India Information